GIUV2016-312
We are the "Excellence PROMETHEUS PHASE II Group" of the GVA, G24 member of the Networked Biomedical Research Centre on Mental Health (CIBERSAM-ISCIII). Since 2013 we are active partners in Europe within the European Innovation Partnership on Active and Healthy Ageing (Acción 3) Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA) Programme; we actively participate in defining a clinically useful position on Mild Cognitive Decline. We direct and coordinate the Assessment Unit for Personal Autonomy, Dependency and Mental Disorders (TMAP) located at the Faculty of Medicine UCIM-INCLIVA, with a service offer including biomechanical and neurocognitive assessments as part of the prevention of fragility signs in populations at risk. The TMAP Unit is the pioneer in carrying out and implementing assessments for patients with mental disorders and / or cognitive and functional deterioration in a comprehensive and personalised manner. These assessments are necessary to determine how people cope with everyday activities in case of disease or deterioration, and to provide them with useful information in order to apply measures allowing for an...We are the "Excellence PROMETHEUS PHASE II Group" of the GVA, G24 member of the Networked Biomedical Research Centre on Mental Health (CIBERSAM-ISCIII). Since 2013 we are active partners in Europe within the European Innovation Partnership on Active and Healthy Ageing (Acción 3) Cognitive Decline Group of the European Innovation Partnership for Active and Healthy Ageing (EIPAHA) Programme; we actively participate in defining a clinically useful position on Mild Cognitive Decline. We direct and coordinate the Assessment Unit for Personal Autonomy, Dependency and Mental Disorders (TMAP) located at the Faculty of Medicine UCIM-INCLIVA, with a service offer including biomechanical and neurocognitive assessments as part of the prevention of fragility signs in populations at risk. The TMAP Unit is the pioneer in carrying out and implementing assessments for patients with mental disorders and / or cognitive and functional deterioration in a comprehensive and personalised manner. These assessments are necessary to determine how people cope with everyday activities in case of disease or deterioration, and to provide them with useful information in order to apply measures allowing for an healthy and independent life. From the group's formation in 2001 to its consolidation in 2007, work was carried out to contribute to the knowledge of cognitive and functional deficits of serious mental illnesses, with a special focus on schizophrenic and bipolar patients and their first-degree relatives. Currently, our knowledge is also focused on direct and inverse Multimorbidity in patients with complex diseases such as CNS disorders, cancer or metabolic diseases. The group can also be found in research areas such as: studies on disease burden (Global Burden of Disease studies), systematic review and networked meta-analysis, neurogenetics and cell therapy (stem cells,) and, finally, Nutritional Psychiatry.
[Read more][Hide]
[Read more][Hide]
- Prevencion de los signos de fragilidad en poblaciones de riesgo desde la valoracion de las funciones humanas (Funcional-cognitiva)
- Consensos para una medicina nutricional en la psiquiatria moderna
- Comprender las asociaciones inesperadas entre enfermedades aparentemente distintas como el Cancer/Sistema Nervioso Central
- Continuar con los estudios de aumento de la carga de enfermedad debida a los trastornos mentales y a las enfermedades neurologicas como las demencia
- Cognitive endophenotypes and biomarkers in schizophrenic / bipolar patients and their first-degree relatives.Molecular and genetic basis of neurocognitive alterations in patients with SMI, in order to develop biomarkers, diagnostic assessment tools and therapeutic interventions helping to improve the functional prognosis, the autonomy and the life quality of these people.
- Global burden of disease.Networking on the burden of disease.
- Direct and inverse multimorbidity in patients with complex diseases like CNS disorders, cancer or metabolic diseases..Comprehend the unexpected associations between apparently different diseases, like cancer and certain diseases of the central nervous system.
- Fragility prevention.Prevention of fragility signs in populations at risk by assessing human functions (functional and neurocognitive assessment) and by incorporating nutritional medicine studies on Omega 3.
| Name | Nature of participation | Entity | Description |
|---|---|---|---|
| RAFAEL TABARES SEISDEDOS | Director | Universitat de València | |
| Research team | |||
| MANUEL GOMEZ BENEYTO | Member | Universitat de València - Estudi General | UVEG honorary professor |
| GABRIEL SELVA VERA | Member | Universitat de València | |
| INMACULADA FUENTES DURA | Collaborator | Universitat de València | |
| VICENTE BALANZA MARTINEZ | Collaborator | Universitat de València | |
| PATRICIA MARIA CORREA GHISAYS | Collaborator | Universitat de València | |
| PATRICIA MARIA CORREA GHISAYS | Collaborator | Centro de Investigación Biomédica en Red de Salud Mental | postdoctoral researcher |
- -
- Medicine
- Trastorno Mental Graves TMG, Psiquiatría, Bipolares, esquizofrenia, depresión
- GBD, carga de enfermedad, TMG, Demencia
- Cáncer, sistema nervioso central
- Fragilidad, medicina nutricional, biomecanica, valoración funcional, neurocognición, Omega3, envejecimiento, demencia,
